Original Literature | Model OverView |
---|---|
Publication
Title
Negative regulation of cytoplasmic RNA-mediated antiviral signaling.
Affiliation
Department of Medicine, Northwestern University, Evanston, IL 60208, USA.
Abstract
The recent, rapid progress in our understanding of cytoplasmic RNA-mediatedantiviral innate immune signaling was initiated by the discovery of retinoicacid-inducible gene I (RIG-I) as a sensor of viral RNA. It is now widelyrecognized that RIG-I and related RNA helicases, melanomadifferentiation-associated gene-5 (MDA5) and laboratory of genetics andphysiology-2 (LGP2), can initiate and/or regulate RNA and virus-mediated type IIFN production and antiviral responses. As with other cytokine systems,production of type I IFN is a transient process, and can be hazardous to thehost if unregulated, resulting in chronic cellular toxicity or inflammatory andautoimmune diseases. In addition, the RIG-I-like receptor (RLR) system is afundamental target for virus-encoded immune suppression, with many indirect anddirect examples of interference described. In this article, we review thecurrent understanding of endogenous negative regulation in RLR signaling andexplore direct inhibition of RLR signaling by viruses as a host immune evasionstrategy.
PMID
18703349
|
Entity
NF-kappaB
--
MO000000058
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m26
10
infinite
0
TRANSPATH | MO000000058 |
--
TNF-alpha
--
MO000000289
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m230
10
infinite
0
InterPro | IPR003636 |
TRANSPATH | MO000000289 |
--
IKK-i
--
MO000016608
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1599
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000016608 |
--
IFNbeta
--
MO000016660
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1636
10
infinite
0
InterPro | IPR000471 |
TRANSPATH | MO000016660 |
--
TRAF3
--
MO000016963
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1872
10
infinite
0
InterPro | IPR001841 |
TRANSPATH | MO000016963 |
--
TBK1
--
MO000019331
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m3902
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000019331 |
--
IRF-3{p}
--
MO000041456
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m19324
10
infinite
0
TRANSPATH | MO000041456 |
--
MAVS
--
MO000094908
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m68199
10
infinite
0
TRANSPATH | MO000094908 |
--
RNF125
--
MO000107907
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m80707
10
infinite
0
TRANSPATH | MO000107907 |
--
--
e1
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m1
0
infinite
0
--
Poly I:C:IFIH1:MAVS:TRAF3
--
e10
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m10
0
infinite
0
--
ssRNA:DDX58
--
e11
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m11
0
infinite
0
--
POly I:C
--
e12
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m12
0
infinite
0
--
Poly I:C: IFIH1
--
e13
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m13
0
infinite
0
--
LGP2
--
e14
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m14
0
infinite
0
--
LGP2
--
e15
cso30:c:mRNA
cso30:i:CC_Cytosol
--
csml-variable:Double
m15
0
infinite
0
--
ROS
--
e16
cso30:c:Protein
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m16
0
infinite
0
--
RIG-I
--
e17
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m17
0
infinite
0
--
MAVS
--
e18
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m18
0
infinite
0
--
DDX58:dsRNA:MAVS
--
e19
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m19
0
infinite
0
--
--
e2
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m2
0
infinite
0
--
DDX58:dsRNA:MAVS:LGP2
--
e20
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m20
0
infinite
0
--
Poly I:C:IFIH1:MAVS
--
e21
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m21
0
infinite
0
--
Poly I:C:IFIH1:MAVS:LGP2
--
e22
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m22
0
infinite
0
--
ssRNA:DDX58(2)
--
e23
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m23
0
infinite
0
--
ssRNA:DDX58:LGP2
--
e24
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m24
0
infinite
0
--
TNF
--
e25
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m25
0
infinite
0
--
DDX58:dsRNA:MAVS:TRAF3:TBK1:IKK-i
--
e26
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m27
0
infinite
0
--
Poly I:C:IFIH1:MAVS:TRAF3:TBK1:IKK-i
--
e27
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m28
0
infinite
0
--
IRF-3{p}:IRF-3{p}
--
e28
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m29
0
infinite
0
--
IRF-3{p}:IRF-3{p}
--
e29
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m30
0
infinite
0
--
--
e3
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m3
0
infinite
0
--
IRF-3{p}:IRF-3{p}:DNA
--
e30
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m31
0
infinite
0
--
csml-variable:Double
m32
0
infinite
0
--
IRF-3{p}:Pin1
--
e32
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m33
0
infinite
0
--
Trans IRF-3{p}:Pin1
--
e33
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m34
0
infinite
0
--
Pin1:p53
--
e34
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m35
0
infinite
0
--
Trans IRF-3{p}{ub}:Pin1
--
e35
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m36
0
infinite
0
--
SIKE
--
e36
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m37
0
infinite
0
--
SIKE:TBK1:IKK-i
--
e37
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m38
0
infinite
0
--
ATG5:ATG12
--
e38
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m39
0
infinite
0
--
DDX58:dsRNA:ATG5:ATG12
--
e39
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m40
0
infinite
0
--
--
e4
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m4
0
infinite
0
--
Poly I:C:IFIH1:ATG5:ATg12
--
e40
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m41
0
infinite
0
--
MAVS:ATG5:ATG12
--
e41
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m42
0
infinite
0
--
RNF125:UbcH8
--
e42
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m43
0
infinite
0
--
RNF125:dsRNA:DDX58
--
e43
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m44
0
infinite
0
--
RNF125:dsRNA:DDX58{ub}
--
e44
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m45
0
infinite
0
--
RNF125:Poly i:C:IFIH1
--
e45
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m46
0
infinite
0
--
RNF125:Poly i:C:IFIH1{ub}
--
e47
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m48
0
infinite
0
--
TRIM25
--
e48
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m49
0
infinite
0
--
DDX58{ub}:dsRNA
--
e49
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m63
0
infinite
0
--
DDX58:dsRNA
--
e5
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m5
0
infinite
0
--
--
e50
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m50
0
infinite
0
--
--
e51
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m51
0
infinite
0
--
--
e52
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m52
0
infinite
0
--
--
e53
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m53
0
infinite
0
--
--
e54
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m54
0
infinite
0
--
--
e55
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m55
0
infinite
0
--
--
e56
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m56
0
infinite
0
--
--
e57
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m57
0
infinite
0
--
--
e58
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m58
0
infinite
0
--
--
e59
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m59
0
infinite
0
--
ssRNA
--
e6
cso30:c:Rna
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m6
0
infinite
0
--
--
e60
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m60
0
infinite
0
--
--
e61
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m61
0
infinite
0
--
--
e62
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m62
0
infinite
0
--
DUBA
--
e63
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m64
0
infinite
0
--
DDX58:dsRNA:MAVS:TRAF3
--
e64
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m65
0
infinite
0
--
G protein
--
e65
cso30:c:Protein
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m66
0
infinite
0
--
DDX58:dsRNA:G protein
--
e66
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m67
0
infinite
0
--
V protein
--
e67
cso30:c:Protein
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m68
0
infinite
0
--
Poly I:C:IFIH1:V protein
--
e68
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m69
0
infinite
0
--
NS1
--
e69
cso30:c:Protein
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m70
0
infinite
0
--
--
e7
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell
--
--
--
csml-variable:Double
m7
0
infinite
0
--
NS1:PKR
--
e70
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m71
0
infinite
0
--
PRR ligand
--
e71
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m72
0
infinite
0
--
CYLD:TBK1:IKK-i
--
e72
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m73
0
infinite
0
--
IFN
--
e73
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m74
0
infinite
0
--
IFN
--
e74
cso30:c:Protein
cso30:i:CC_Extracellular
--
csml-variable:Double
m75
0
infinite
0
--
csml-variable:Double
m76
0
infinite
0
--
DDX58{ub}:dsRNA:CYLD
--
e76
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
csml-variable:Double
m77
0
infinite
0
--
DDX58{ub}:dsRNA:CYLD
--
e77
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
csml-variable:Double
m78
0
infinite
0
--
csml-variable:Double
m79
0
infinite
0
--
POly I:C:IFIH1:DAK
--
e79
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m80
0
infinite
0
--
--
e8
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell_WithoutCellWall_
--
--
--
csml-variable:Double
m8
0
infinite
0
--
CYLD{p}:TBK1:IKK-i
--
e80
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m81
0
infinite
0
--
NLRX1
--
e81
cso30:c:Protein
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m82
0
infinite
0
--
NLRX1:MAVS
--
e82
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m83
0
infinite
0
--
Shigella
--
e84
cso30:c:Cell
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m85
0
infinite
0
--
NS3
--
e85
cso30:c:Protein
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m86
0
infinite
0
--
Hepatitis C virus polyprotein
--
e86
cso30:c:Protein
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m87
0
infinite
0
--
Cleaved fragments
--
e87
cso30:c:EntityBiological
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m88
0
infinite
0
--
Cleaved trif fragment1
--
e88
cso30:c:Protein
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m89
0
infinite
0
--
Cleaved trif fragment2
--
e89
cso30:c:Protein
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m90
0
infinite
0
--
--
e9
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m9
0
infinite
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c1 : 1
stoichiometry:c2 : 1
stoichiometry:c3 : 1
m119368*m41844*0.1
nodelay
--
0
PMID: 18703349,17038590,17038589 This RIG-I region has the ability to recognize 5¡ì-triphosphorylated ends of double-stranded (ds) or single-stranded (ss) RNA
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c20 : 1
stoichiometry:c22 : 1
stoichiometry:c164 : 1
stoichiometry:c23 : 1
m5*m68199*0.1
nodelay
--
0
PMID: 18703349,17020950 Mechanistic experiments found that LGP2 co-immunoprecipitates with the adaptor protein, IPS-1/MAVS/CARDIF/VISA, and exhibits competitive binding with the downstream kinase, IKKi/IKK¦Å for a common site in IPS-1 PMID: 18703349 Mechanistic studies suggests that NLRX1 competes with RIG-I for IPS-1 interaction, implying that association between RIG-I and IPS-1 through CARD?CARD interaction is disrupted by NLRX1 in the mitochondrial compartment.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c26 : 1
stoichiometry:c29 : 1
stoichiometry:c31 : 1
m21*m14*0.1
nodelay
--
0
PMID: 18703349, 17020950 Mechanistic experiments found that LGP2 co-immunoprecipitates with the adaptor protein, IPS-1/MAVS/CARDIF/VISA, and exhibits competitive binding with the downstream kinase, IKKi/IKK¦Å for a common site in IPS-1
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c21 : 1
stoichiometry:c27 : 1
stoichiometry:c28 : 1
m13*m68199*0.1
nodelay
--
0
PMID: 18703349,17020950 Mechanistic experiments found that LGP2 co-immunoprecipitates with the adaptor protein, IPS-1/MAVS/CARDIF/VISA, and exhibits competitive binding with the downstream kinase, IKKi/IKK¦Å for a common site in IPS-1
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c32 : 1
stoichiometry:c37 : 1
stoichiometry:c33 : 1
m11*0.1
nodelay
--
0
PMID: 18703349,17190814 LGP2 has also been demonstrated to associate with RIG-I to inhibit its auto-oligomerizaton via the LGP2 C-terminal region comparable to the RIG-I RD PMID: 18703349,18243112 In this model, dimerization of RIG-I by 5¡ì-triphosphorylated ssRNA, proposed to be an active form of RIG-I , is replaced by a RIG-I:LGP2 hetero-oligomer.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c34 : 1
stoichiometry:c35 : 1
stoichiometry:c36 : 1
m11*m14*0.1
nodelay
--
0
PMID: 18703349, 17020950 Mechanistic experiments found that LGP2 co-immunoprecipitates with the adaptor protein, IPS-1/MAVS/CARDIF/VISA, and exhibits competitive binding with the downstream kinase, IKKi/IKK¦Å for a common site in IPS-1 PMID: 18703349,18243112 In this model, dimerization of RIG-I by 5¡ì-triphosphorylated ssRNA, proposed to be an active form of RIG-I , is replaced by a RIG-I:LGP2 hetero-oligomer.
p15
p15
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c38 : 1
stoichiometry:c39 : 1
m1585*0.1
nodelay
--
0
PMID:18703349,2118515 A20 was originally identified as a TNF-inducible gene in human umbilical vein endothelial cells and was found to be induced by a wide range of stimuli including NF-KappaB
p16
p16
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c40 : 1
stoichiometry:c41 : 1
m26*0.1
nodelay
--
0
PMID:18703349,2118515 A20 was originally identified as a TNF-inducible gene in human umbilical vein endothelial cells and was found to be induced by a wide range of stimuli including NF-KappaB
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c42 : 1
stoichiometry:c43 : 1
m93378*0.1
nodelay
--
0
PMID:18703349,2118515 A20 was originally identified as a TNF-inducible gene in human umbilical vein endothelial cells and was found to be induced by a wide range of stimuli including NF-KappaB
p18
p18
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c44 : 1
stoichiometry:c46 : 1
stoichiometry:c45 : 1
stoichiometry:c47 : 1
m3902*m1599*m65*0.1
nodelay
--
0
PMID: 18703349, 17020950 Mechanistic experiments found that LGP2 co-immunoprecipitates with the adaptor protein, IPS-1/MAVS/CARDIF/VISA, and exhibits competitive binding with the downstream kinase, IKKi/IKK¦Å for a common site in IPS-1 PMID: 18703349 Experiments indicate that A20 intervenes downstream of the mitochondrial adaptor protein IPS-1 but upstream of the kinases (TBK1 and IKKi) that phosphorylate IRF-3.
p18
p19
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c48 : 1
stoichiometry:c49 : 1
stoichiometry:c121 : 1
stoichiometry:c50 : 1
m3902*m1599*m10*0.1
nodelay
--
0
PMID: 18703349, 17020950 Mechanistic experiments found that LGP2 co-immunoprecipitates with the adaptor protein, IPS-1/MAVS/CARDIF/VISA, and exhibits competitive binding with the downstream kinase, IKKi/IKK¦Å for a common site in IPS-1 PMID: 18703349 Experiments indicate that A20 intervenes downstream of the mitochondrial adaptor protein IPS-1 but upstream of the kinases (TBK1 and IKKi) that phosphorylate IRF-3.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c4 : 1
stoichiometry:c5 : 1
stoichiometry:c6 : 1
m6*m41844*0.1
nodelay
--
0
PMID: 18703349,17038590,17038589 This RIG-I region has the ability to recognize 5¡ì-triphosphorylated ends of double-stranded (ds) or single-stranded (ss) RNA
p20
p20
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c51 : 1
stoichiometry:c52 : 1
stoichiometry:c54 : 1
stoichiometry:c177 : 1
stoichiometry:c53 : 1
m27*m977*0.1
nodelay
--
0
PMID: 18703349,12702807 The NS3/4A protease function was known to be essential for proper posttranslational cleavage of the hepatitis C virus polyprotein when it was also identified as responsible for inhibition of IRF3 phosphorylation
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c55 : 1
stoichiometry:c56 : 1
m19324*0.1
nodelay
--
0
PMID: 18703349,15474016,16306043,15661910 Expression of A20 blocks the constitutively active RIG-I N-terminus from signaling IRF-3 phosphorylation, dimerization, and DNA binding as well as Sendai virus, NDV and dsRNA-mediated IFNbeta promoter activity
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c57 : 1
stoichiometry:c58 : 1
m29*0.1
nodelay
--
0
PMID: 18703349,15474016,16306043,15661910 Expression of A20 blocks the constitutively active RIG-I N-terminus from signaling IRF-3 phosphorylation, dimerization, and DNA binding as well as Sendai virus, NDV and dsRNA-mediated IFNbeta promoter activity
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c59 : 1
stoichiometry:c60 : 1
stoichiometry:c61 : 1
m30*m32*0.1
nodelay
--
0
PMID: 18703349,15474016,16306043,15661910 Expression of A20 blocks the constitutively active RIG-I N-terminus from signaling IRF-3 phosphorylation, dimerization, and DNA binding as well as Sendai virus, NDV and dsRNA-mediated IFNbeta promoter activity
p24
p24
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c62 : 1
stoichiometry:c63 : 1
stoichiometry:c64 : 1
m19324*m2065*0.1
nodelay
--
0
PMID: 18703349 Due to a neighboring proline at position 340, phosphorylation of Ser 339 produces a binding site for the WW domain of the peptidyl-prolyl isomerase, Pin1.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c65 : 1
stoichiometry:c67 : 1
stoichiometry:c66 : 1
m33*0.1
nodelay
--
0
PMID: 18703349 This interaction possibly subjects IRF3 to cis?trans isomerization around the Ser-Pro peptide bond.
p26
p26
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c68 : 1
stoichiometry:c69 : 1
stoichiometry:c70 : 1
m2065*m220*0.1
nodelay
--
0
PMID: 18703349,12397362,12397361 For example, Pin1 association with the tumor suppressor p53 generates conformational changes that enhances transactivation activity
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c71 : 1
stoichiometry:c72 : 1
m34*0.1
nodelay
--
0
PMID: 18703349 For IRF-3, Pin1 association was demonstrated to facilitate ubiquitin-mediated proteosomal degradation.
p28
p28
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c73 : 1
stoichiometry:c74 : 1
stoichiometry:c75 : 1
stoichiometry:c76 : 1
m37*m1599*m3902*0.1
nodelay
--
0
PMID: 18703349,16281057 Suppressor of IKK-epsilon, SIKE, has been identified as an IKKepsilon-associated protein by yeast two-hybrid screening PMID: 18703349 Further characterization of SIKE revealed that it also can associates with TBK1 and that SIKE expression can efficiently inhibit IKK¦Å, TBK1, TRIF, TLR3 and RIG-I-mediated IFN¦Â and interferon stimulated response element (ISRE) promoter activation.
p29
p29
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c77 : 1
stoichiometry:c78 : 1
stoichiometry:c79 : 1
m45270*m42024*0.1
nodelay
--
0
PMID: 18703349 The small ubiquitin-like Atg12 becomes conjugated to its substrate, Atg5, to produce the Atg5?Atg12 conjugate, a key regulator of the autophagic process that associates directly with the CARD domains of RIG-I, MDA5 and IPS-1.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c7 : 1
stoichiometry:c8 : 1
stoichiometry:c9 : 1
m12*m76904*0.1
nodelay
--
0
PMID: 18703349,16625202,16714379 For MDA5 neither biological substrate specificity nor exact RNA binding have been clearly specified experimentally, however MDA5 is thought to be the primary receptor for signaling initiated by cytoplasmic accumulation of the well-studied synthetic dsRNA analog, poly(I:C)
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c80 : 1
stoichiometry:c81 : 1
stoichiometry:c82 : 1
m39*m5*0.1
nodelay
--
0
PMID: 18703349 The small ubiquitin-like Atg12 becomes conjugated to its substrate, Atg5, to produce the Atg5?Atg12 conjugate, a key regulator of the autophagic process that associates directly with the CARD domains of RIG-I, MDA5 and IPS-1.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c83 : 1
stoichiometry:c84 : 1
stoichiometry:c85 : 1
m39*m13*0.1
nodelay
--
0
PMID: 18703349 The small ubiquitin-like Atg12 becomes conjugated to its substrate, Atg5, to produce the Atg5?Atg12 conjugate, a key regulator of the autophagic process that associates directly with the CARD domains of RIG-I, MDA5 and IPS-1.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c86 : 1
stoichiometry:c87 : 1
stoichiometry:c88 : 1
m68199*m39*0.1
nodelay
--
0
PMID: 18703349 The small ubiquitin-like Atg12 becomes conjugated to its substrate, Atg5, to produce the Atg5?Atg12 conjugate, a key regulator of the autophagic process that associates directly with the CARD domains of RIG-I, MDA5 and IPS-1.
p33
p33
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c89 : 1
stoichiometry:c90 : 1
stoichiometry:c91 : 1
m80707*m22076*0.1
nodelay
--
0
PMID: 18703349 RNF125 was identified as an UbcH8 interacting protein by yeast two-hybrid screening based on the prediction that UbcH8, which is an E2 enzyme for both ubiquitin and ISG15, might associate with the E3 ligase for RIG-I.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c92 : 1
stoichiometry:c94 : 1
stoichiometry:c93 : 1
m80707*m5*0.1
nodelay
--
0
PMID: 18703349 The N-terminal region of RNF125 associates with RIG-I via the CARD and RNA helicase domain but not with the RD, and expression of RNF125 increases RIG-I ubiquitination and destabilization.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c95 : 1
stoichiometry:c96 : 1
m44*0.1
nodelay
--
0
PMID: 18703349 The N-terminal region of RNF125 associates with RIG-I via the CARD and RNA helicase domain but not with the RD, and expression of RNF125 increases RIG-I ubiquitination and destabilization.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c97 : 1
stoichiometry:c98 : 1
m80707*m13*0.1
nodelay
--
0
PMID: 18703349 Both MDA5 and IPS-1 were also shown to be ubiquitination targets of RNF125.
p36
p37
cso30:i:ME_Ubiquitination
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c100 : 1
stoichiometry:c101 : 1
stoichiometry:c102 : 1
m80707*m68199*0.1
nodelay
--
0
PMID: 18703349 Both MDA5 and IPS-1 were also shown to be ubiquitination targets of RNF125.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c99 : 1
stoichiometry:c103 : 1
stoichiometry:c104 : 1
m13*m80707*0.1
nodelay
--
0
PMID: 18473349 Both MDA5 and IPS-1 were also shown to be ubiquitination targets of RNF125.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c105 : 1
stoichiometry:c106 : 1
m46*0.1
nodelay
--
0
PMID: 18703349 Both MDA5 and IPS-1 were also shown to be ubiquitination targets of RNF125.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c10 : 1
stoichiometry:c11 : 1
m5*0.1
nodelay
--
0
PMID: 18703349 Moreover, it was observed that LGP2 mRNA and protein are inducible by dsRNA or IFN treatments as well as virus infection, consistent with LGP2 functioning as a negative feedback regulator.
p40
p40
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c107 : 1
stoichiometry:c109 : 1
stoichiometry:c128 : 1
stoichiometry:c130 : 1
stoichiometry:c108 : 1
m93217*m27*0.1
nodelay
--
0
PMID: 18473349 As a result, virus or dsRNA-mediated IFN¦Â production is inhibited by expression of RNF125 and enhanced by RNF125 knock-down. PMID: 18703349 Coexpression studies of RIG-I and MDA5 with the hMPV G protein revealed that the G protein can specifically block RIG-I-mediated IFNbeta induction.
p40
p41
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c110 : 1
stoichiometry:c111 : 1
stoichiometry:c129 : 1
stoichiometry:c134 : 1
stoichiometry:c154 : 1
stoichiometry:c112 : 1
m93217*m28*0.1
nodelay
--
0
PMID: 18473349 As a result, virus or dsRNA-mediated IFN¦Â production is inhibited by expression of RNF125 and enhanced by RNF125 knock-down. PMID: 18703349,15563593,15563593 A wide variety of paramyxoviruses target MDA5 but not RIG-I via their V protein and can specifically block MDA5-mediated IFN induction PMID: 18703349 Expression of DAK inhibits MDA5-mediated IFN¦Â and ISRE reporter gene activity, but not RIG-I, IPS-1 or TLR3 activity.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c113 : 1
stoichiometry:c114 : 1
stoichiometry:c115 : 1
m49*m5*0.1
nodelay
--
0
PMID: 18703349 This residue of RIG-I, located in the CARD region, is a target for efficient TRIM25-induced ubiquitination that is essential for antiviral signaling.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c116 : 1
stoichiometry:c117 : 1
m1872*m64*0.1
nodelay
--
0
PMID:18703349 A biochemical approach has identified TNF receptor-associated factor 3 (TRAF3) as a DUBA interacting protein.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c118 : 1
stoichiometry:c119 : 1
stoichiometry:c120 : 1
m1872*m21*0.1
nodelay
--
0
PMID: 18703349,16858409 TRAF3 directly associates with IPS-1 to induce IFNs in RLR signaling by linking TBK1/IKKepsilon kinases
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c122 : 1
stoichiometry:c123 : 1
stoichiometry:c124 : 1
m19*m1872*0.1
nodelay
--
0
PMID: 18703349,16858409 TRAF3 directly associates with IPS-1 to induce IFNs in RLR signaling by linking TBK1/IKKepsilon kinases
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c125 : 1
stoichiometry:c126 : 1
stoichiometry:c127 : 1
m5*m66*0.1
nodelay
--
0
PMID: 18703349,18516301 In addition, RIG-I and the G protein were shown to co-precipitate in co-expression studies as well as in hMPV infected cells
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c131 : 1
stoichiometry:c132 : 1
stoichiometry:c133 : 1
m68*m13*0.1
nodelay
--
0
PMID: 18703349,15563593 MDA5 was isolated in a screen for immunoprecipitated host cell proteins that interact with the V protein of parainfluenza virus 5 (PIV5)
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c135 : 1
stoichiometry:c136 : 1
stoichiometry:c137 : 1
m70*m1055*0.1
nodelay
--
0
PMID: 18703349,9971827,9781815 NS1 has been demonstrated to inactivate several immune effectors, including the downregulation of cellular mRNA processing,interaction and blocking of PKR and s well as RNA sequestration from 2¡ì5¡ì-OAS activation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c138 : 1
stoichiometry:c140 : 1
stoichiometry:c141 : 1
stoichiometry:c139 : 1
m74*m72*0.1
nodelay
--
0
PMID: 18703349,10933707,11090154 IFN production is highly elevated in cells infected with NS1 deficient influenza A strains compared to cells infected with wild-type virus , and overexpression of NS1 can block IFN production by other viruses or PRR ligands
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c12 : 1
stoichiometry:c13 : 1
m15*0.1
nodelay
--
0
PMID: 18703349 Moreover, it was observed that LGP2 mRNA and protein are inducible by dsRNA or IFN treatments as well as virus infection, consistent with LGP2 functioning as a negative feedback regulator.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c142 : 1
stoichiometry:c143 : 1
stoichiometry:c144 : 1
m70*m19*0.1
nodelay
--
0
PMID: 18703349 For example, antiviral signaling induced by ectopic expression of IPS-1 is also inhibited by NS1 and both RIG-I and NS1 co-fractionate with IPS-1 in an insoluble cell fraction
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c145 : 1
stoichiometry:c146 : 1
stoichiometry:c147 : 1
stoichiometry:c149 : 1
m19042*m63*0.1
nodelay
--
0
PMID: 18703349 CYLD associates with the CARD domain of RIG-I and removes K63-linked ubiquitin from the RIG-I CARDs that are conjugated by the E3 ubiquitin ligase, TRIM25.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c148 : 1
stoichiometry:c150 : 1
m77*0.1
nodelay
--
0
PMID: 18703349 CYLD associates with the CARD domain of RIG-I and removes K63-linked ubiquitin from the RIG-I CARDs that are conjugated by the E3 ubiquitin ligase, TRIM25.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c151 : 1
stoichiometry:c152 : 1
stoichiometry:c153 : 1
m13*m79*0.1
nodelay
--
0
PMID: 18703349 In immunoprecipitation experiments, DAK associates with MDA5 but not RIG-I, and the CARD domain-containing fragment of MDA5 is sufficient for the association.
p54
p54
cso30:i:ME_Binding
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c155 : 1
stoichiometry:c156 : 1
stoichiometry:c157 : 1
stoichiometry:c158 : 1
m19042*m3902*m1599*0.1
nodelay
--
0
PMID: 18703349 Immunoprecipitation experiments show that CYLD coprecipitates not only with RIG-I but also with TBK1 and IKKepsilon.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c159 : 1
stoichiometry:c160 : 1
m73*0.1
nodelay
--
0
PMID: 18703349 Interestingly, TBK1 or IKKepsilon but not RIG-I specifically precipitates two species of CYLD in size, suggesting phosphorylation of CYLD by these kinases.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c161 : 1
stoichiometry:c162 : 1
stoichiometry:c163 : 1
m82*m68199*0.1
nodelay
--
0
PMID: 18703349 Intriguingly, association between endogenous NLRX1 and IPS-1 is observed and the interaction is mediated by the CARD-like domain of IPS-1 and a putative nucleotide-binding domain (NBD) of NLRX1
p57
p57
cso30:i:ME_UnknownProduction
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c165 : 1
stoichiometry:c167 : 1
stoichiometry:c166 : 1
m230*m82*0.1
nodelay
--
0
PMID: 180703349,18219313 NLRX1 synergistically potentiates ROS production induced by TNFalpha, Shigella infection and double-stranded RNA treatment, resulting in amplified NF-¦ÊB-dependent and JUN amino-terminal kinases-dependent signaling
p57
p58
cso30:i:ME_UnknownProduction
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c168 : 1
stoichiometry:c169 : 1
stoichiometry:c170 : 1
m84*m82*m16*0.1
nodelay
--
0
PMID: 180703349,18219313 NLRX1 synergistically potentiates ROS production induced by TNFalpha, Shigella infection and double-stranded RNA treatment, resulting in amplified NF-¦ÊB-dependent and JUN amino-terminal kinases-dependent signaling
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c171 : 1
stoichiometry:c172 : 1
stoichiometry:c173 : 1
m85*m82*0.1
nodelay
--
0
PMID: 180703349,18219313 NLRX1 synergistically potentiates ROS production induced by TNFalpha, Shigella infection and double-stranded RNA treatment, resulting in amplified NF-¦ÊB-dependent and JUN amino-terminal kinases-dependent signaling
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c14 : 1
stoichiometry:c15 : 1
m75*0.1
nodelay
--
0
PMID: 18703349 Moreover, it was observed that LGP2 mRNA and protein are inducible by dsRNA or IFN treatments as well as virus infection, consistent with LGP2 functioning as a negative feedback regulator.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c174 : 1
stoichiometry:c175 : 1
stoichiometry:c176 : 1
m86*m87*0.1
nodelay
--
0
PMID: 18703349,12702807 The NS3/4A protease function was known to be essential for proper posttranslational cleavage of the hepatitis C virus polyprotein when it was also identified as responsible for inhibition of IRF3 phosphorylation
p61
p61
cso30:i:ME_Cleavage
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c178 : 1
stoichiometry:c179 : 1
stoichiometry:c180 : 1
stoichiometry:c181 : 1
m86*m18998*0.1
nodelay
--
0
PMID: 18703349,15710891 Sequence alignments of known NS3/4A specific cleavage sites in components of TLR3 signaling revealed a potential cleavage site in TRIF/TICAM-1 (Toll-IL-1 receptor domain-containing adaptor inducing IFNbeta), an adaptor molecule in the TLR3 signaling pathway. In vitro cleavage assays confirmed the predicted cleavage of TRIF into two fragments, both incapable of IFNbeta induction
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c16 : 1
stoichiometry:c17 : 1
1.0*0.1
nodelay
--
0
PMID: 18703349,16127453,16177806,16125763,16153868 Alternatively, it was found that LGP2 can suppress IFN¦Â promoter activity induced by non-RNA activators, including expression of the constitutively active RIG-I N-terminal CARD fragment or the signaling adaptor molecule IPS-1/MAVS/CARDIF/VISA from plasmid vectors.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c18 : 1
stoichiometry:c19 : 1
1.0*0.1
nodelay
--
0
PMID: 18703349,16127453,16177806,16125763,16153868 Alternatively, it was found that LGP2 can suppress IFN¦Â promoter activity induced by non-RNA activators, including expression of the constitutively active RIG-I N-terminal CARD fragment or the signaling adaptor molecule IPS-1/MAVS/CARDIF/VISA from plasmid vectors.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c30 : 1
stoichiometry:c24 : 1
stoichiometry:c25 : 1
m14*m19*0.1
nodelay
--
0
PMID: 18703349, 17020950 Mechanistic experiments found that LGP2 co-immunoprecipitates with the adaptor protein, IPS-1/MAVS/CARDIF/VISA, and exhibits competitive binding with the downstream kinase, IKKi/IKK¦Å for a common site in IPS-1
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--